obesity drug news today glp-1 september 22 2025 Alarming rise in weight loss overdoses GLP-1 weight loss drugs are

2024;44(4):NP279NP306

3.7 Cancer risk by individual GLP-1 RA compound When stratified by individual GLP-1 RAs, liraglutide and semaglutide were associated with reduced risk of gastrointestinal cancers (HR 0.77 and 0.79, respectively), while dulaglutide showed a neutral association (HR 0.91, 95% CI: 0.721.14)

In the future, the researchers hope to clarify the long-term impact of GLP-1 medications, the HFpEF subpopulations that may derive the most benefit from them, and whether the drugs are also effective in reducing other cardiovascular risks

And, if you are paying in cash for the Zepbound KwikPen, the prices start at $299 per month for the 2.5 mg dose and scale up depending on the dose you need